Cargando…
Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate
COVID-19 is the pandemic outbreak that is caused by SARS-CoV-2 virus from December, 2019. Human race do not know the curative measure of this devastating disease. In today’s era of nanotechnology, it may use its knowledge to develop molecular vaccine to combat this disease. In this article we are in...
Autor principal: | Acharya, Rituparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346779/ https://www.ncbi.nlm.nih.gov/pubmed/32663741 http://dx.doi.org/10.1016/j.mehy.2020.110084 |
Ejemplares similares
-
Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007) -
Letter to the editor: Does Dicer Expression Affect shRNA processing?
por: Senzer, Neil, et al.
Publicado: (2009) -
Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse Colitis
por: Bao, Wei-Lian, et al.
Publicado: (2021) -
Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010) -
Specific interference shRNA-expressing plasmids inhibit Hantaan virus infection in vitro and in vivo
por: Liu, Yuan-yuan, et al.
Publicado: (2016)